NYSE: SIShoulder Innovations Inc Stock
$14.60-0.08 (-0.54%)
Updated Apr 2, 2026
SI Price
$14.60
Fair Value Price
N/A
Market Cap
$301.45M
52 Week Low
$10.92
52 Week High
$17.94
P/E
-3.14x
P/B
2.14x
P/S
2.62x
PEG
N/A
Dividend Yield
N/A
Revenue
$47.32M
Earnings
-$40.36M
Gross Margin
76.5%
Operating Margin
-85.15%
Profit Margin
-85.3%
Debt to Equity
0.21
Operating Cash Flow
-$29M
Beta
0.77
Next Earnings
May 7, 2026
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SI's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
SI
Ranked#77 of 100
Ranked#77 of 100
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.97 | A | |
| $9.63 | A | |
| $24.60 | A |
Be the first to know about important SI news, forecast changes, insider trades & much more!
SI News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SI is good value based on its book value relative to its share price (2.14x), compared to the US Medical Devices industry average (3.27x)
P/B vs Industry Valuation
SI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SI due diligence checks available for Premium users.
Valuation
SI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.14x
Industry
23.94x
Market
30.13x
SI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.14x
Industry
3.27x
SI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SI's financial health
Profit margin
Revenue
$14.4M
Net Income
-$7.8M
Profit Margin
-53.9%
SI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$169.9M
Liabilities
$29.2M
Debt to equity
0.21
SI's short-term assets ($157.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SI's short-term assets ($157.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$8.8M
Investing
-$17.3M
Financing
-$2.0M
SI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SI vs Medical Device Stocks
Shoulder Innovations Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.